Objective: To determine whether a solution of bupivacaine (Marcain [As
tra]), adrenaline and cocaine (MAC) is as safe and effective as tetrac
aine, adrenaline and cocaine (TAG) as topical anaesthesia for wound su
turing. Design: Double-blind, randomised, prospective trial. Setting:
Emergency departments of two tertiary referral hospitals (one speciali
sing in paediatric care) in Adelaide, South Australia, between Februar
y 1992 and April 1994. Participants: 181 patients, aged six or older,
with simple dermal lacerations less than 5 mm deep, not involving muco
us membranes or areas with end-arterial blood supply. Interventions: P
atients received a weight-adjusted dose of either MAC or TAG. Outcome
measures: Needle-prick testing of wound for pain before suturing, pain
ratings by patients and physicians during suturing, signs and symptom
s of cocaine toxicity, wound complications and patient preference for
topical anaesthesia. Results: Topical anaesthesia was adequate for sut
uring in 73% of patients (83% of those with head wounds and 56% of tho
se with extremity wounds). MAC and TAC did not differ significantly in
efficacy overall or by wound location. Pain ratings from patients tre
ated with MAC and TAC were comparable, as was patient acceptance of to
pical anaesthesia (77%, MAC; 81%, TAG) and the incidence of adverse ef
fects (4% infection rate overall). Conclusions: Topical anaesthesia is
a safe and effective means of anaesthetising selected lacerations for
suturing. As we found no significant differences in either the effica
cy or safety of the two solutions, we believe that MAC can be substitu
ted for the less readily available TAC whenever expedient.